Start for free
Start for free
IC

IRIS Capital Investment

Europe, Ile-de-France, France, Neuilly-sur-seine

Description

IRIS Capital Investment is an independent provider of capital to publicly-listed companies.

Investor Profile

IRIS Capital Investment has made 6 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series A (33%)
  • Series Unknown (17%)

Country Focus

  • France (83%)
  • South Korea (17%)

Industry Focus

  • Pharmaceutical
  • Biotechnology
  • Health Diagnostics
  • Communities
  • E-commerce
  • Sharing Economy
  • Financial Services
  • Fintech
  • Document Management
  • Law Enforcement
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does IRIS Capital Investment frequently co-invest with?

HD
Habert Dassault Finance
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Elevation Capital Partners
Elevation Capital Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Laguna Investment
Laguna Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
D·CAMP
D·CAMP
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
TC
TDH Capital
North America, Pennsylvania, United States, Radnor
Co-Investments: 2
saltlux
saltlux
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Hana Financial Investment
Hana Financial Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
BD
Banque des Territoires
Europe, Ile-de-France, France, Paris
Co-Investments: 2

What are some of recent deals done by IRIS Capital Investment?

Median Technologies

Valbonne, Provence-Alpes-Cote d'Azur, France

MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, screening, and clinical practice.

Clinical TrialsHealth CareOncologyPharmaceutical
Post Ipo EquityJan 24, 2025
Amount Raised: $10,481,499
Poxel

Lyon, Rhone-Alpes, France

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo EquityMar 23, 2023
Amount Raised: $3,792,118
Poxel

Lyon, Rhone-Alpes, France

Poxel is a research integrated pharmaceutical company that develops products for metabolic diseases.

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo EquityAug 8, 2022
Amount Raised: $6,119,015
Amicus Lex

Yongdungpo, Seoul-t'ukpyolsi, South Korea

Amicus Lex is a provider of legal and professional services.

Document ManagementLaw EnforcementLegalProfessional ServicesService Industry
Series AApr 11, 2022
Amount Raised: $2,833,572
YouScribe

Paris, Ile-de-France, France

YouScribe is a community platform for sharing and selling digital publications in France.

CommunitiesE-CommerceSharing Economy
Series UnknownFeb 11, 2022
Amount Raised: $5,675,498
Youdge

Levallois-perret, Ile-de-France, France

Youdge is a digital neo-broker with a aim to make the consumer credit market clear and accessible.

Financial ServicesFinTech
Series AOct 29, 2021
Amount Raised: $5,780,547
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator